Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Julia Hippisley-Cox a Division of General Practice, Nottingham
University, Nottingham NG7 2RD, b Collingham Medical
Centre, High Street, Collingham NG23 7LB, c School of Nursing, Medical School,
Queen's Medical Centre, Nottingham NG7 2UH
Correspondence to: J
Hippisley-Cox julia.hippisley-cox{at}nottingham.ac.uk
Objective:
To study differences in treatment for men and women with ischaemic heart disease by using standards defined in
England's national service framework for coronary artery
disease.
What is already known on this topic
What this study adds
Design:
Cross sectional survey using routinely
collected data.
Setting:
18 practices in 18 primary care groups in Trent Region.
Subjects:
5891 men and women aged over 35 years with a
diagnosis of ischaemic heart disease or prescription for nitrates recorded on computer.
Main outcome measure:
Difference in the proportion of
men and women with ischaemic heart disease and taking lipid lowering treatment.
Results:
Women were less likely than men to have a recording of body mass index (79% (2197/2783) v 82%
(2552/3102), P=0.002), smoking (86% (2386) v 89% (2779),
P<0.0001), and blood pressure (95% (2643) v 96% (2986),
P=0.04). Women were also less likely to have a recording of fasting
cholesterol concentration (35% (968) v 50% (1550),
P<0.0001) but were more likely to be obese (25% (558/2197)
v 20% (514/2552), P<0.0001) and have their most recently
recorded blood pressure value over the recommended 140/85 mm Hg (60%
(1598/2643) v 52% (1553/2986), P<0.0001). Although a
higher proportion of women had a raised serum cholesterol concentration (77% (749/968) v 67% (1043/1550), P<0.0001), men were
more likely to take aspirin (76% (2358) v 71% (1979),
P<0.0001), have a recorded diagnosis of hyperlipidaemia (13% (418)
v 10% (274), P<0.0001), and be prescribed lipid lowering
drugs (31% (973) v 21% (596), P<0.0001). These
differences remained despite adjustments for the practice where the
patient is registered, age, smoking status, obesity, diabetes, and hypertension.
Conclusion:
The results suggest a systematic bias
towards men compared with women in terms of secondary prevention of
ischaemic heart disease.
England's national service framework for coronary artery disease
requires general practitioners to identify and treat patients at high
risk of ischaemic heart disease
Among patients with ischaemic heart disease, men were more likely than
women to have cardiovascular risk factors and serum cholesterol
concentration recorded on computer
Read all Rapid Responses